Chromosome Imbalance and Its Clinical Significance

Definition and Importance

Chromosome imbalance, whether due to a numeric or structural change, is a leading cause of developmental and intellectual disabilities. Approximately 1 in 4 live births with a chromosome abnormality are affected by an imbalance, which can result in a wide range of clinical outcomes, from mild to severe intellectual and developmental disabilities.

• Chromosome imbalance: A condition where there is an abnormal number or structure of chromosomes, leading to gene dosage changes.

• Clinical impact: Can cause syndromes such as Down syndrome (trisomy 21), DiGeorge syndrome (22q11.2 deletion), and others.

• Detection: Historically detected by cytogenetic banding and karyotyping, but newer molecular methods have improved sensitivity and resolution.

Chromosome Analysis Methods

Traditional Cytogenetic Techniques

Conventional chromosome analysis uses metaphase spreads and banding techniques to visualize chromosomes and detect large-scale abnormalities. However, these methods have limited resolution and may miss submicroscopic changes.

• G-banding: Staining technique that produces characteristic banding patterns for each chromosome, allowing identification of large deletions, duplications, or translocations.

• Limitations: Cannot detect small (submicroscopic) copy number changes or subtle structural rearrangements.

Fluorescence In Situ Hybridization (FISH)

FISH uses fluorescent probes that bind to specific DNA sequences on chromosomes, enabling detection of known microdeletions or duplications.

• Application: Used for targeted analysis of specific syndromes (e.g., DiGeorge syndrome, Williams syndrome).

• Advantages: Higher resolution than karyotyping; can detect submicroscopic changes.

• Limitations: Only detects abnormalities for which probes are designed; not genome-wide.

Genomic Microarrays

Principles and Types

Genomic microarrays are high-resolution tools that allow genome-wide detection of copy number variations (CNVs), including deletions and duplications too small to be seen by traditional cytogenetics.

• Array Comparative Genomic Hybridization (aCGH): Compares patient DNA to a reference, identifying gains or losses of chromosomal material.

• SNP Arrays: Detect both CNVs and regions of homozygosity, which can indicate uniparental disomy or consanguinity.

• Resolution: Can detect changes as small as a few kilobases, depending on probe density.

Applications and Advantages

• Genome-wide screening: Allows for unbiased detection of chromosomal imbalances without prior knowledge of the region involved.

• Clinical utility: Has led to the identification of new syndromes and improved diagnosis of unexplained developmental delay, intellectual disability, and congenital anomalies.

• Limitations: Cannot detect balanced rearrangements (e.g., translocations or inversions) that do not change copy number.

Table: Comparison of Chromosome Analysis Methods

Interpretation of Copy Number Alterations

Pathogenicity and Clinical Relevance

Not all detected CNVs are clinically significant. Interpretation requires comparison to databases of known benign and pathogenic variants, as well as consideration of inheritance patterns and clinical presentation.

• Pathogenic CNVs: Clearly associated with disease phenotypes (e.g., 22q11.2 deletion syndrome).

• Variants of Uncertain Significance (VUS): CNVs with unclear clinical impact; may require parental testing or further research.

• Benign CNVs: Common in the general population and not associated with disease.

New Syndrome Identification Using Microarray Analysis

Discovery of Novel Disorders

Microarray analysis has enabled the identification of new syndromes by revealing recurrent CNVs in patients with similar clinical features. This has expanded our understanding of the genetic basis of developmental disorders.

• Example: Identification of 17q21.31 microdeletion syndrome and other novel syndromes through analysis of patient cohorts.

• Research impact: Facilitates genotype-phenotype correlations and guides further genetic and functional studies.

Summary

Advances in postnatal diagnostic methods, particularly the use of genomic microarrays, have greatly improved the detection and characterization of chromosome disorders. These technologies provide higher resolution, genome-wide analysis, and have led to the discovery of new syndromes and improved patient care. However, careful interpretation of results is essential to distinguish pathogenic changes from benign variation.